Net Income (Loss) Attributable to Parent in USD of Ocean Biomedical, Inc. from Q2 2021 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Ocean Biomedical, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2021 to Q1 2025.
  • Ocean Biomedical, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2025 was -$8.24M, a 163% decline year-over-year.
  • Ocean Biomedical, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2025 was -$30.7M, a 4.58% decline year-over-year.
  • Ocean Biomedical, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$9.48M, a 91.7% increase from 2023.
  • Ocean Biomedical, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$114M, a 559% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

Ocean Biomedical, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$30.7M -$8.24M -$21.2M -163% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q4 2024 -$9.48M -$1.54M +$15.3M +90.9% Oct 1, 2024 Dec 31, 2024 10-K 2025-04-08
Q3 2024 -$24.8M -$3.7M +$10.4M +73.7% Jul 1, 2024 Sep 30, 2024 10-K 2025-04-08
Q2 2024 -$35.2M -$17.2M -$5.8M -50.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-12-23
Q1 2024 -$29.4M $13M +$85.1M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q4 2023 -$114M -$16.9M -$15.9M -1615% Oct 1, 2023 Dec 31, 2023 10-K 2025-04-08
Q3 2023 -$98.6M -$14.1M -$10.4M -284% Jul 1, 2023 Sep 30, 2023 10-Q 2025-01-13
Q2 2023 -$88.2M -$11.4M -$4.1M -55.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-12-23
Q1 2023 -$84.1M -$72.1M -$66.7M -1241% Jan 1, 2023 Mar 31, 2023 10-Q 2024-12-23
Q4 2022 -$17.4M -$983K Oct 1, 2022 Dec 31, 2022 10-K 2024-11-25
Q3 2022 -$3.67M -$3.63M -8521% Jul 1, 2022 Sep 30, 2022 10-Q 2024-04-15
Q2 2022 -$7.33M -$7.33M Apr 1, 2022 Jun 30, 2022 10-Q/A 2024-04-15
Q1 2022 -$5.38M Jan 1, 2022 Mar 31, 2022 10-Q/A 2024-04-15
Q3 2021 -$42.5K Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-17
Q2 2021 -$82* Jun 17, 2021 Jun 30, 2021 10-Q 2022-10-17

Ocean Biomedical, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$9.48M +$105M +91.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-08
2023 -$114M -$97.1M -559% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-08
2022 -$17.4M Jan 1, 2022 Dec 31, 2022 10-K 2024-11-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.